BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 12529274)

  • 1. Angiotensin II and renal medullary blood flow in Lyon rats.
    Sarkis A; Liu KL; Lo M; Benzoni D
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F365-72. PubMed ID: 12529274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of perindopril on renal medullary hemodynamics in genetically hypertensive rats.
    Liu KL; Lo M; Benzoni D
    Am J Hypertens; 2006 Jun; 19(6):617-22. PubMed ID: 16733235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
    Muller C; Endlich K; Barthelmebs M; Helwig JJ
    Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
    Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
    Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of angiotensin II on blood circulation in the renal medulla and cortex of anaesthetised rats.
    Badzyńska B; Grzelec-Mojzesowicz M; Dobrowolski L; Sadowski J
    J Physiol; 2002 Jan; 538(Pt 1):159-66. PubMed ID: 11773324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins but not nitric oxide protect renal medullary perfusion in anaesthetised rats receiving angiotensin II.
    Badzyńska B; Grzelec-Mojzesowicz M; Sadowski J
    J Physiol; 2003 May; 548(Pt 3):875-80. PubMed ID: 12640010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors.
    Ognibene DT; Oliveira PR; Marins de Carvalho LC; Costa CA; Espinoza LA; Criddle DN; Tano T; Soares de Moura R; Resende AC
    Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):12-9. PubMed ID: 18986337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation.
    Zou AP; Wu F; Cowley AW
    Hypertension; 1998 Jan; 31(1 Pt 2):271-6. PubMed ID: 9453315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II and neurohumoral control of the renal medullary circulation.
    Evans RG; Head GA; Eppel GA; Burke SL; Rajapakse NW
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e58-69. PubMed ID: 19566838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of renal medullary circulation by the renin-angiotensin system in genetically hypertensive rats.
    Liu KL
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):455-61. PubMed ID: 19215237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide.
    Fernandes L; Loiola RA; Tostes RC; Nigro D; Fortes ZB; de Carvalho MH
    Peptides; 2005 Dec; 26(12):2458-63. PubMed ID: 16043265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
    Gohlke P; Pees C; Unger T
    Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.
    de Richelieu LT; Sorensen CM; Holstein-Rathlou NH; Salomonsson M
    Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1227-34. PubMed ID: 16033921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local renal medullary L-NAME infusion enhances the effect of long-term angiotensin II treatment.
    Szentiványi M; Maeda CY; Cowley AW
    Hypertension; 1999 Jan; 33(1 Pt 2):440-5. PubMed ID: 9931144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.